These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 19786442)
1. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Kuzniewicz MW; Escobar GJ; Newman TB Pediatrics; 2009 Oct; 124(4):1031-9. PubMed ID: 19786442 [TBL] [Abstract][Full Text] [Related]
2. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. Bhutani VK; Stark AR; Lazzeroni LC; Poland R; Gourley GR; Kazmierczak S; Meloy L; Burgos AE; Hall JY; Stevenson DK; J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study. Kuzniewicz MW; Escobar GJ; Wi S; Liljestrand P; McCulloch C; Newman TB J Pediatr; 2008 Aug; 153(2):234-40. PubMed ID: 18534217 [TBL] [Abstract][Full Text] [Related]
4. Effect of universal neonatal transcutaneous bilirubin screening on blood draws for bilirubin analysis and phototherapy usage. Wickremasinghe AC; Karon BS; Saenger AK; Cook WJ J Perinatol; 2012 Nov; 32(11):851-5. PubMed ID: 22343396 [TBL] [Abstract][Full Text] [Related]
5. Validity of transcutaneous bilirubin measurements during and after phototherapy in term and late preterm infants. Thamwiriyakul N; Siripattanapipong P; Bowornkitiwong W; Chaweerat R; Ngerncham S Eur J Pediatr; 2024 Nov; 183(11):5037-5041. PubMed ID: 39271553 [TBL] [Abstract][Full Text] [Related]
6. Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline? Atkinson LR; Escobar GJ; Takayama JI; Newman TB Pediatrics; 2003 May; 111(5 Pt 1):e555-61. PubMed ID: 12728109 [TBL] [Abstract][Full Text] [Related]
7. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy. Chang PW; Kuzniewicz MW; McCulloch CE; Newman TB Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196932 [TBL] [Abstract][Full Text] [Related]
8. Hyperbilirubinemia screening and treatment in neonates born prior to 35 weeks of gestation. Khan S; Coo H; Khurshid F J Neonatal Perinatal Med; 2024; 17(2):177-182. PubMed ID: 38427505 [TBL] [Abstract][Full Text] [Related]
9. Implementation of a neonatal transcutaneous bilirubin screening programme in rural India. Morgan MC; Kumar GS; Kaiser SV; Seetharam S; Ruel TD Paediatr Int Child Health; 2016 May; 36(2):122-6. PubMed ID: 25844503 [TBL] [Abstract][Full Text] [Related]
10. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536 [TBL] [Abstract][Full Text] [Related]
11. Changes in total serum bilirubin during phototherapy in late preterm and term infants with non-haemolytic hyperbilirubinemia. Dani C; Becciani S; Pratesi S Early Hum Dev; 2019 Apr; 131():41-44. PubMed ID: 30831388 [TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia. Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578 [TBL] [Abstract][Full Text] [Related]
13. The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyperbilirubinemia. Berkwitt A; Osborn R; Grossman M Hosp Pediatr; 2015 Feb; 5(2):74-8. PubMed ID: 25646199 [TBL] [Abstract][Full Text] [Related]
14. Association Between Laboratory Calibration of a Serum Bilirubin Assay, Neonatal Bilirubin Levels, and Phototherapy Use. Kuzniewicz MW; Greene DN; Walsh EM; McCulloch CE; Newman TB JAMA Pediatr; 2016 Jun; 170(6):557-61. PubMed ID: 27064480 [TBL] [Abstract][Full Text] [Related]
16. Hour-Specific Total Serum Bilirubin Percentiles for Infants Born at 29-35 Weeks' Gestation. Jegathesan T; Ray JG; Bhutani VK; Keown-Stoneman CDG; Campbell DM; Shah V; Berger H; Hayeems RZ; Sgro M; Neonatology; 2021; 118(6):710-719. PubMed ID: 34710869 [TBL] [Abstract][Full Text] [Related]
17. Systematic review of screening for bilirubin encephalopathy in neonates. Trikalinos TA; Chung M; Lau J; Ip S Pediatrics; 2009 Oct; 124(4):1162-71. PubMed ID: 19786450 [TBL] [Abstract][Full Text] [Related]
18. Total serum bilirubin exceeding exchange transfusion thresholds in the setting of universal screening. Flaherman VJ; Kuzniewicz MW; Escobar GJ; Newman TB J Pediatr; 2012 May; 160(5):796-800.e1. PubMed ID: 22133423 [TBL] [Abstract][Full Text] [Related]
19. Early Hyperbilirubinemia in Neonates with Down Syndrome. Bahr TM; Henry E; Hulse W; Baer VL; Prchal JT; Bhutani VK; Christensen RD J Pediatr; 2020 Apr; 219():140-145. PubMed ID: 32014279 [TBL] [Abstract][Full Text] [Related]
20. Rate of rise of total serum bilirubin in very low birth weight preterm infants. Hahn S; Bührer C; Schmalisch G; Metze B; Berns M Pediatr Res; 2020 May; 87(6):1039-1044. PubMed ID: 31086285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]